| The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications N Mitsiades, CS Mitsiades, PG Richardson, V Poulaki, YT Tai, D Chauhan, ... Blood, The Journal of the American Society of Hematology 101 (6), 2377-2380, 2003 | 934 | 2003 |
| Molecular sequelae of proteasome inhibition in human multiple myeloma cells N Mitsiades, CS Mitsiades, V Poulaki, D Chauhan, G Fanourakis, X Gu, ... Proceedings of the National Academy of Sciences 99 (22), 14374-14379, 2002 | 931 | 2002 |
| Molecular sequelae of histone deacetylase inhibition in human malignant B cells N Mitsiades, CS Mitsiades, PG Richardson, C McMullan, V Poulaki, ... Blood, The Journal of the American Society of Hematology 101 (10), 4055-4062, 2003 | 368 | 2003 |
| Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro CS Mitsiades, D McMillin, V Kotoula, V Poulaki, C McMullan, J Negri, ... The Journal of Clinical Endocrinology & Metabolism 91 (10), 4013-4021, 2006 | 158 | 2006 |
| Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas V Poulaki, CS Mitsiades, C McMullan, D Sykoutri, G Fanourakis, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5392-5398, 2003 | 146 | 2003 |
| Novel histone deacetylase inhibitors in the treatment of thyroid cancer CS Mitsiades, V Poulaki, C McMullan, J Negri, G Fanourakis, ... Clinical Cancer Research 11 (10), 3958-3965, 2005 | 117 | 2005 |
| Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis CS Mitsiades, V Kotoula, V Poulaki, E Sozopoulos, J Negri, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3662-3666, 2006 | 78 | 2006 |
| Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation CS Mitsiades, V Poulaki, G Fanourakis, E Sozopoulos, D McMillin, Z Wen, ... Clinical cancer research 12 (12), 3705-3712, 2006 | 75 | 2006 |
| Targeting BRAFV600E in thyroid carcinoma: therapeutic implications CS Mitsiades, J Negri, C McMullan, DW McMillin, E Sozopoulos, ... Molecular cancer therapeutics 6 (3), 1070-1078, 2007 | 73 | 2007 |
| Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing V Poulaki, CS Mitsiades, C McMullan, G Fanourakis, J Negri, ... Investigative ophthalmology & visual science 46 (1), 358-366, 2005 | 59 | 2005 |
| Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas V Kotoula, E Sozopoulos, H Litsiou, G Fanourakis, T Koletsa, G Voutsinas, ... Endocrine-related cancer 16 (2), 565, 2009 | 57 | 2009 |
| RANKL and OPG mRNA level after non-surgical periodontal treatment XE Dereka, CE Markopoulou, G Fanourakis, S Tseleni-Balafouta, ... Inflammation 33, 200-206, 2010 | 55 | 2010 |
| Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation A Saetta, G Fanourakis, E Agapitos, PS Davaris Cardiovascular Pathology 9 (3), 181-183, 2000 | 38 | 2000 |
| Expression of MMPs and TIMP‐1 in smoker and nonsmoker chronic periodontitis patients before and after periodontal treatment E Mouzakiti, E Pepelassi, G Fanourakis, C Markopoulou, ... Journal of periodontal research 47 (4), 532-542, 2012 | 32 | 2012 |
| Expression of receptor activator of NF‐κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws G Fanourakis, AC Lazaris, S Krithinakis, KI Tosios, A Sklavounou, ... Journal of oral pathology & medicine 39 (9), 687-689, 2010 | 22 | 2010 |
| Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma S Tseleni-Balafouta, H Gakiopoulou, G Fanourakis, G Voutsinas, ... Experimental and molecular pathology 80 (2), 177-182, 2006 | 20 | 2006 |
| The effect of smoking on the mRNA expression of MMPs and TIMP‐1 in untreated chronic periodontitis patients: a cross‐sectional study E Mouzakiti, E Pepelassi, G Fanourakis, C Markopoulou, ... Journal of periodontal research 46 (5), 576-583, 2011 | 16 | 2011 |
| Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas G Fanourakis, K Tosios, N Papanikolaou, I Chatzistamou, M Xydous, ... Experimental and molecular pathology 101 (3), 314-319, 2016 | 14 | 2016 |
| Fibrillin expression and localization in various types of carcinomas of the thyroid gland S Tseleni-Balafouta, H Gakiopoulou, G Fanourakis, G Voutsinas, H Litsiou, ... Modern pathology 19 (5), 695-700, 2006 | 14 | 2006 |
| Hsp90 inhibitors prolong survival in a SCID/NOD mice model of diffuse multiple myeloma: therapeutic implications CS Mitsiades, N Mitsiades, V Poulaki, G Fanourakis, T Hideshima, ... Blood 100 (11), 2002 | 10 | 2002 |
